CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
CBD Life Sciences, Inc. (CBDL) is set to launch a groundbreaking nutritional supplement powder infused with mushroom extracts, projected to increase company revenue by 20% in the first year. The supplement contains a proprietary blend of reishi mushroom, lion's mane mushroom, and ashwagandha root extracts, offering stress reduction, brain health support, and immune system enhancement.
Key benefits include:
- Reishi extract: Immune-boosting and potential tumor growth inhibition
- Lion's mane extract: Cognitive function enhancement and nerve regeneration
- Ashwagandha root: Stress reduction and anti-inflammatory effects
The global supplement market is expected to reach $18 billion by 2028, positioning CBDL to capture a substantial market share with this innovative product launch.
CBD Life Sciences, Inc. (CBDL) si appresta a lanciare un innovativo integratore nutrizionale in polvere infuso con estratti di funghi, previsto per incrementare il fatturato dell'azienda del 20% nel primo anno. L'integratore contiene una miscela esclusiva di estratti di fungo reishi, fungo lion's mane e radice di ashwagandha, offrendo riduzione dello stress, supporto per la salute cerebrale e potenziamento del sistema immunitario.
I principali benefici includono:
- Estratto di reishi: Potenziamento del sistema immunitario e potenziale inibizione della crescita dei tumori
- Estratto di lion's mane: Miglioramento della funzione cognitiva e rigenerazione dei nervi
- Radice di ashwagandha: Riduzione dello stress ed effetti antinfiammatori
Si prevede che il mercato globale degli integratori raggiunga 18 miliardi di dollari entro il 2028, posizionando CBDL per catturare una quota di mercato considerevole con il lancio di questo prodotto innovativo.
CBD Life Sciences, Inc. (CBDL) se prepara para lanzar un innovador polvo de suplemento nutricional infusionado con extractos de hongos, proyectado para incrementar los ingresos de la empresa en un 20% en el primer año. El suplemento contiene una mezcla exclusiva de extractos de hongo reishi, hongo melena de león y raíz de ashwagandha, ofreciendo reducción de estrés, apoyo para la salud cerebral y mejora del sistema inmunológico.
Los beneficios clave incluyen:
- Extracto de reishi: Aumento de la inmunidad y posible inhibición del crecimiento de tumores
- Extracto de melena de león: Mejora de la función cognitiva y regeneración de nervios
- Raíz de ashwagandha: Reducción del estrés y efectos antiinflamatorios
Se espera que el mercado global de suplementos alcance 18 mil millones de dólares para 2028, posicionando a CBDL para capturar una porción considerable del mercado con este lanzamiento de producto innovador.
CBD 라이프 사이언스, Inc. (CBDL)은 혁신적인 영양 보충제 파우더를 버섯 추출물로 주입하여 출시할 예정이며, 첫 해에 회사 수익을 20% 증가시킬 것으로 예상됩니다. 이 보충제는 영지버섯, 사자 갈기버섯, 그리고 아쉬와간다 뿌리 추출물의 독점 혼합물을 포함하여 스트레스 감소, 뇌 건강 지원, 면역 체계 강화의 효과를 제공합니다.
주요 이점은 다음과 같습니다:
- 영지 추출물: 면역력 증진 및 종양 성장 억제 가능성
- 사자갈기 추출물: 인지 기능 향상 및 신경 재생
- 아쉬와간다 뿌리: 스트레스 감소 및 항염 효과
전 세계 보충제 시장은 2028년까지 180억 달러에 이를 것으로 예상되며, CBDL은 이 혁신적인 제품 출시를 통해 상당한 시장 점유율을 확보할 수 있을 것으로 보입니다.
CBD Life Sciences, Inc. (CBDL) s'apprête à lancer un complément nutritionnel en poudre révolutionnaire infusé avec des extraits de champignons, prévu pour augmenter les revenus de l'entreprise de 20 % la première année. Le complément contient un mélange exclusif d'extraits de champignon reishi, de champignon crinière de lion et d'extraits de racine d'ashwagandha, offrant une réduction du stress, un soutien à la santé cérébrale et un renforcement du système immunitaire.
Les principaux avantages incluent :
- Extrait de reishi : Renforcement du système immunitaire et inhibition potentielle de la croissance tumorale
- Extrait de crinière de lion : Amélioration de la fonction cognitive et régénération des nerfs
- Racine d'ashwagandha : Réduction du stress et effets anti-inflammatoires
Le marché mondial des compléments est prévu d'atteindre 18 milliards de dollars d'ici 2028, positionnant CBDL pour capturer une part de marché significative avec ce lancement de produit innovant.
CBD Life Sciences, Inc. (CBDL) plant die Einführung eines bahnbrechenden Nahrungsergänzungsmittels in Pulverform, das mit Pilzextrakten angereichert ist und voraussichtlich den Unternehmensumsatz im ersten Jahr um 20 % steigern wird. Das Supplement enthält eine proprietäre Mischung aus Reishi-Extrakt, Löwenmähne-Pilz und Ashwagandha-Wurzeln, die Stressabbau, Unterstützung der Gehirngesundheit und Verbesserung des Immunsystems bietet.
Wesentliche Vorteile umfassen:
- Reishi-Extrakt: Immunstärkung und potenzielle Hemmung des Tumorwachstums
- Löwenmähne-Extrakt: Verbesserung der kognitiven Funktion und Regeneration von Nerven
- Ashwagandha-Wurzel: Stressabbau und entzündungshemmende Wirkung
Der globale Markt für Nahrungsergänzungsmittel wird voraussichtlich bis 2028 18 Milliarden Dollar erreichen, was CBDL in die Lage versetzt, mit dieser innovativen Produkteinführung einen erheblichen Marktanteil zu gewinnen.
- Projected 20% increase in company revenue within the first year
- Tapping into the rapidly growing $18 billion wellness market
- Unique blend of ingredients offering multiple health benefits
- Potential for slowing tumor growth with reishi mushroom extract
- None.
Projected to increase company revenue by
SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.
Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being.
Unrivaled Benefits of Key Ingredients:
Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today.
Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity.
Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery.
Revenue Projections & Market Potential
With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences, Inc.'s annual revenue. Analysts expect the market for mushroom-infused supplements to reach
A Vision for the Future
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated, "We are incredibly excited to bring this innovative product to the market. With the growing demand for natural, scientifically backed health solutions, we believe this supplement will be a game-changer, not only for our company but for the health-conscious consumers we serve."
About CBD Life Sciences, Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based & organic products including, Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, Roll-on's, Salve, Full Pet Line, Pre-Rolls, Full Line of Spa Products, Sleep & Anxiety Edibles. The CBD Vault's products can be viewed and purchased on the Company's website www.thecbdvault.com.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
Related Images
|
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What is the new product launched by CBD Life Sciences (CBDL)?
How much is CBDL's revenue expected to increase with the new product launch?
What are the key ingredients in CBDL's new nutritional supplement?
What is the projected market size for mushroom-infused supplements by 2028?
